The next live-webinar "Expanding Frontiers: Evaluating Finerenone in Type 1 Diabetes and CKD – Insights from the FINE-ONE Trial" takes place on 7 October 2026, 18:00–18:45 CEST. 

Learning objectives:

• Advancing early diagnosis and screening of heart failure with preserved ejection fraction (HFpEF) to enable timely and more accurate identification in routine care

• Optimizing integrated management of heart failure, chronic kidney disease, and type 2 diabetes to improve clinical outcomes across the cardio-renal-metabolic continuum

• Translating current guideline recommendations (ADA, KDIGO and ESC HF) on non-steroidal MRAs and SGLT-2 inhibitors into daily clinical practice

• Interpreting key evidence from landmark trials (e.g., FINEARTS-HF, FINE-ONE, CONFIDENCE, FIDELIO-DKD, FIGARO-DKD, FIDELITY) to support treatment decisions

   

 All webinars and webcasts since 2024 are available in English and also with Chinese subtitles.